News | October 18, 2021
WHO to take call on Covaxin's EUL on October 26th
The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17
The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17
U.S. FDA to decide whether to authorize a booster dose in the coming days
First anticipated spinout from the alliance, Circle Therapeutics, to develop novel muscle stem cell therapies for a variety of skeletal muscle disorders
Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations
_256_384.jpg)
The two doses of Covaxin are likely to be administered to children with a gap of 28 days
The test kit uses a reagent developed using Kaneka's molecular testing-related technologies
If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19
Quantitative restrictions in place to meet domestic needs to cater to the vaccination programme
The aim is to first produce Covid-19 vaccines and then add more vaccines in the years to come
Now all districts of the country will have commissioned PSA Oxygen plants
Subscribe To Our Newsletter & Stay Updated
